Medicare Advantage Challenges: 2023 Stent Declines Medigap Access
Published on Β· Source: finance.yahoo.com

AI Summary
Summarized by AI from the source belowA 71-year-old Florida widow faced difficulties switching from her Medicare Advantage plan after a stent was placed in 2023, leading to denials from insurers for Medigap Plan G. Federal law allows a guaranteed-issue window for Medigap for six months starting at age 65 with Part B enrollment. After this period, carriers can evaluate medical histories, which may result in declined applications based on conditions like recent stents or high blood pressure. This situation highlights important factors for retirees considering their health coverage options in relation to Medicare plans, which may significantly impact their financial planning.
Informational only, not financial advice. Content is AI-generated and may contain errors. How this works.
Get the weekly market brief
One email every Monday: what moved, why, and what to watch. Free, unsubscribe anytime.
Get stories like this as they break
Our Telegram channel posts every market story the moment it is published. Free, and you can mute or leave anytime.
Related News

BrainsWay Expands U.S. Insurance Coverage to 70M Lives
Oct 13

Kodiak Sciences (KOD) Target Raised by H.C. Wainwright on Trial Data
Oct 12

Tax Cuts Could Lead to Social Security and Medicare Reductions
Oct 10

Medicare Advantage Plans Unavailable in 181 Counties by 2027
Oct 10